1 October we become SureStone CapitalSame team, same ABN. Our website and email addresses move to surestone.com.au.
Preparing video
BlinkLab has partnered with the Thompson Center for Autism & Neurodevelopment to advance the main study phase of its pivotal FDA 510(k) diagnostic trial.
Recognised as a leading US hub for neurodevelopmental care, the Thompson Center will serve as a key clinical research site.
The trial for BlinkLab Dx 1, aimed at autism diagnosis, is moving from its pilot phase into full study, with results expected soon. Completion is targeted for the second quarter of 2026, with FDA submission anticipated in the third quarter of that year.
Corporate Travel Management will remain in a trading halt as it is unable to fully audit its FY25 results.
The company says its auditor has raised issues with revenue and costs in the European division.
Corporate Travel has told investors to expect an update in November, after results were originally due in August.
In a statement, it said FY25 earnings are expected to be lower than the year prior, though cash reserves and 2026 operations should not be affected.
Its cash balance was about $124 million at the end of June.
Paladin Energy shares are falling on a discounted $300 million equity raise.
Tuesday’s offer price of $7.25 a share represents an 8% discount to Monday’s close.
Meanwhile, Brazilian Rare Earths has hit a 15-month high on a new rare earth discovery in the country.
BHP will sack 750 workers, blaming the impact of high royalties imposed by the Queensland government for the losses.
The BHP Mitsubishi Alliance says its Saraji South mine will cease operations from November, with BHP also considering shutting its “FutureFit” academy that trains newcomers, particularly women, to join the industry.
"Due to the unsustainable impact of the Queensland Government's coal royalties on business returns, BHP Mitsubishi Alliance is removing approximately 750 roles across Queensland and suspending low-margin operations," BHP said in an emailed statement.
Droneshield has won two new contracts with the US Defence Department worth almost $8 million.
The contracts are for its handheld systems that stop unmanned aerial vehicles from communicating with their controllers. Droneshield has now sold more than 4,000 devices worldwide.
Corporate Travel flags further audit delays this month, advising shareholders to wait until November due to issues with the timing of revenue and cost recognition in its European division. Shares remained suspended after the company missed its initial reporting deadline.
Orion Minerals has signed a deal with global miner Glencore for about US$250 million in funding to finance its Prieska copper-zinc project in South Africa.
GPT Group has appointed Tony Osmond as an independent non-executive director.
Osmond, who will start in March, recently served as Citigroup Australia's Chair of Banking and has served on the boards of the Australian Ballet and Orchestra Victoria.
PYC Therapeutics has named Chair Alan Tribe as managing director following the resignation of CEO Rohan Hockings.
Hockings has given two months’ notice and will leave PYC on 16 November.
Mr Tribe, who joined the board in 2018, will fill the role while a search for a permanent MD is underway.
